These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32480216)

  • 1. Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
    Wu M; Li X; Wang S; Yang S; Zhao R; Xing Y; Liu L
    Biomed Pharmacother; 2020 Aug; 128():110308. PubMed ID: 32480216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.
    Ahmad P; Alvi SS; Iqbal D; Khan MS
    Life Sci; 2020 Aug; 254():117756. PubMed ID: 32389832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydatin alleviated alcoholic liver injury in zebrafish larvae through ameliorating lipid metabolism and oxidative stress.
    Lai Y; Zhou C; Huang P; Dong Z; Mo C; Xie L; Lin H; Zhou Z; Deng G; Liu Y; Chen Y; Huang S; Wu Z; Sun X; Gao L; Lv Z
    J Pharmacol Sci; 2018 Sep; 138(1):46-53. PubMed ID: 30245287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical therapies for atherosclerosis.
    Moss JW; Ramji DP
    Nat Rev Cardiol; 2016 Sep; 13(9):513-32. PubMed ID: 27383080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 6. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 8. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
    Ou H; Huang Z; Mo Z; Xiao J
    Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential applications of mushrooms against some facets of atherosclerosis: A review.
    Amirullah NA; Zainal Abidin N; Abdullah N
    Food Res Int; 2018 Mar; 105():517-536. PubMed ID: 29433243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
    Peng Y; Xu J; Zeng Y; Chen L; Xu XL
    Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo.
    Wang HL; Gao JP; Han YL; Xu X; Wu R; Gao Y; Cui XH
    Phytomedicine; 2015 May; 22(5):553-9. PubMed ID: 25981921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.
    Doustimotlagh AH; Eftekhari M
    Clin Nutr ESPEN; 2021 Jun; 43():197-199. PubMed ID: 34024514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polydatin attenuates spinal cord injury in rats by inhibiting oxidative stress and microglia apoptosis via Nrf2/HO-1 pathway.
    Lv R; Du L; Zhang L; Zhang Z
    Life Sci; 2019 Jan; 217():119-127. PubMed ID: 30481506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydatin Attenuates Atherosclerosis in ApoE
    Huang Z; Tian G; Cheng S; Zhao D; Zhang Y; Jia Y; Zhou F
    Am J Chin Med; 2018; 46(8):1841-1859. PubMed ID: 30537866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters.
    Du J; Sun LN; Xing WW; Huang BK; Jia M; Wu JZ; Zhang H; Qin LP
    Phytomedicine; 2009 Jun; 16(6-7):652-8. PubMed ID: 19106037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of polydatin on multiple organ ischemia-reperfusion injury.
    Sun Z; Wang X
    Bioorg Chem; 2020 Jan; 94():103485. PubMed ID: 31836186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.